Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92037, USA.
Viruses. 2021 Oct 28;13(11):2172. doi: 10.3390/v13112172.
As the first intracellular host factors that directly interact with the genomes of RNA viruses, RNA binding proteins (RBPs) have a profound impact on the outcome of an infection. Recent discoveries brought about by new methodologies have led to an unprecedented ability to peer into the earliest events between viral RNA and the RBPs that act upon them. These discoveries have sparked a re-evaluation of current paradigms surrounding RBPs and post-transcriptional gene regulation. Here, we highlight questions that have bloomed from the implementation of these novel approaches. Canonical RBPs can impact the fates of both cellular and viral RNA during infection, sometimes in conflicting ways. Noncanonical RBPs, some of which were first characterized via interactions with viral RNA, may encompass physiological roles beyond viral pathogenesis. We discuss how these RBPs might discriminate between an RNA of either cellular or viral origin and thus exert either pro- or antiviral effects-which is a particular challenge as viruses contain mechanisms to mimic molecular features of cellular RNA.
作为最初与 RNA 病毒基因组直接相互作用的细胞内宿主因子,RNA 结合蛋白 (RBP) 对感染的结果有着深远的影响。新方法带来的最新发现使我们能够以前所未有的能力深入了解病毒 RNA 与作用于它们的 RBP 之间的最早事件。这些发现引发了对围绕 RBP 和转录后基因调控的现有范式的重新评估。在这里,我们强调了这些新方法实施后出现的问题。在感染过程中,典型的 RBP 可以影响细胞和病毒 RNA 的命运,有时甚至是相互矛盾的方式。非典型的 RBP 中,有些是通过与病毒 RNA 的相互作用首次被描述的,其生理作用可能超出了病毒发病机制的范围。我们讨论了这些 RBP 如何区分细胞或病毒来源的 RNA,从而发挥抗病毒或促病毒作用——这是一个特别的挑战,因为病毒包含了模拟细胞 RNA 分子特征的机制。